R&D Systems™ Human Thrombopoietin/Tpo Recombinant Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 288TP025

Catalog No. 288TP025

Description

The Recombinant Human Thrombopoietin Protein is derived from Sf 21 (baculovirus). The Recombinant Human Thrombopoietin Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
• Molecular Weight (g/mol): 35 kDa
• Quantity: 25μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Purity or Quality Grade: 97%, by SDS-PAGE with silver staining.

• Gene ID (Entrez): 7066
• Name: Thrombopoietin/Tpo
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Thrombopoietin/Tpo protein Ser22-Gly353
• Gene Alias: Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, megakaryocyte stimulating factor, MGDF, MGDFC-mpl ligand, MKCSF, MK-CSF, ML, MPL ligand, MPLLG, MPLLGMGC163194, Myeloproliferative leukemia virus oncogene ligand, THCYT1, THPO, thrombopoietin, thrombopoietin nirs variant 1, Tpo, TPOMKCSF
• Recombinant: Recombinant